Aims This cross-sectional study aimed to analyse myocardial deformation in patients with
Fabry disease (FD) in order to evaluate speckle tracking as a method for non-invasive …

Background Fabry cardiomyopathy is characterized by progressive left ventricular
hypertrophy (LVH) associated with diastolic dysfunction and is the most common cause of …

The aim of this study was to test the hypothesis that in patients with Fabry disease, 2D
speckle-tracking echocardiography (2DSTE) could detect functional myocardial alterations …

Fabry disease (FD) is characterized by left ventricular hypertrophy (LVH). Conventional
echocardiography is not sensitive enough to perform the preclinical diagnosis To assess …

Aims The aim of this clinical cross-sectional study was to investigate the cardiac interrelation
of morphological and functional abnormalities in patients with Fabry disease. Methods and …

Introduction and objectives Cardiac manifestations in Fabry disease are mainly
characterized by left ventricular hypertrophy (LVH). The aims of this study were (1) to …

Aims Fabry cardiomyopathy (FC) is characterized by progressive left ventricular hypertrophy
(LVH). Conventional echocardiography is not sensitive in detecting preclinical FC before the …

Objectives: We hypothesized that Fabry cardiomyopathy in female patients might differ
substantially from that in male patients and sought to prove this hypothesis in a large cohort …

Background Initiation of enzyme replacement therapy (ERT) early in the Fabry disease
course may facilitate better outcomes than in patients with advanced disease. Early …

Background In spite of several research studies help to describe the heart in Fabry disease
(FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure …